Saturday, July 11, 2026

Drug profile · INN

omega-3-acid ethyl esters type a

omega-3-acid ethyl esters type a (OMTRYG) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — omega-3-acid ethyl esters type a
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

omega-3-acid ethyl esters type a (OMTRYG) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN omega-3-acid ethyl esters type a
Brand OMTRYG
Mechanism Unknown
Route ORAL
Formulation CAPSULE

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is omega-3-acid ethyl esters type a?

omega-3-acid ethyl esters type a (OMTRYG) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for omega-3-acid ethyl esters type a?

OMTRYG is a marketed brand name for omega-3-acid ethyl esters type a. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of omega-3-acid ethyl esters type a?

omega-3-acid ethyl esters type a has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.